GOSS
Gossamer Bio, Inc. Common Stock
stockNASDAQ
gossamer bio is a san diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. founded by the former receptos executive team, gossamer bio's strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 9.28 | 2026-10-12 | -9.59% | 5.400 |
| 1M | 10.73 | 2026-09-18 | -21.81% | 1.867 |
| 3M | 11.28 | 2026-07-20 | -25.62% | 1.065 |
| 6M | 33.60 | 2026-04-20 | -75.03% | 1.653 |
| 1Y | 181.60 | 2025-10-20 | -95.38% | 2.170 |
| 2Y | 76.96 | 2024-10-18 | -89.10% | — |
| 5Y | 1,044.00 | 2021-10-19 | -99.20% | 1.433 |
Gossamer Bio, Inc. Common Stock (NASDAQ:GOSS) stock price today is $8.39, and today's volume is 165,177. GOSS is down 4.333% today. The 30 day average volume is 296,956. GOSS market cap is $51.32M with 6.12M shares outstanding.